** Proteomics International Laboratories PIQ.AX jumps as much as 9.5% to A$0.810, highest since Oct. 11
** Medical technology firm says its OxiDx test - a finger-prick blood test to measure oxidative stress - accurately identifies muscle damage in marathon runners
** PIQ sets sights on H1 CY25 for Australian commercial launch of OxiDx test
** More than 540,000 shares traded, 5x the 30-day avg
** Stock trims YTD losses to 12.3%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。